✦ LIBER ✦

PCN72 COST-UTILITY ANALYSIS OF GEFITINIB VERSUS DOCETAXEL IN A MEXICAN PUBLIC INSTITUTION

✍ Scribed by P Anaya; RJ López; AC Polanco

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN32 COST-UTILITY ANALYSIS OF DOCETAXEL

✍ J Walczak; D Pawlik; R Wojcik; M Kaczor; J Lis; G Nogas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PCN68 COST-UTILITY ANALYSIS OF DOCETAXEL

✍ J Walczak; E Gebus; K Lasota; A Semeniuk; D Pawlik; I Malczak; J Lis; M Glasek; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN12 ECONOMIC EVALUATION OF ADJUVANT CH

✍ Erazo-Valle, A; Lazaro, J; Lemus, A; Robles, J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

PCN25 COST-EFFECTIVENESS ANALYSIS OF ERL

✍ Kim, YG; Lee, EK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCN94 Comparative Analysis of Cost-Effec

✍ Arreola Ornelas, H.; Rosado Buzzo, A.; García, L.; Camacho, L.M.; Lechuga, D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PDB60 A Cost-Utility Analysis of Pregaba

✍ B.K. Bellows; A. Dahal; T. Jiao; J. Biskupiak 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB